Title: DOPA Responsive Dystonia Due to GTP Cyclohydrolase -1 Deficieny Caused by PTS Gene Mutation

Authors: Dr Shyam Srinivasan, Dr Devanand Gulab Chaudhari, Dr MD Sabri Ahsan,  Dr Yugesh Kumar Agarwal, Dr Prachi Atmapoojya

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i1.02

Abstract

Dopa-responsive dystonia (DRD) is a childhood-onset dystonic disorder, Characteristic symptoms include dystonia typically absent in the morning or after rest but worsening during the day and with exertion. Few patients may present with signs of Parkinsonism that may include bradykinesia, rigidity, balancing difficulties, and postural instability. The striking feature of this disorder is gradual progression to generalised dystonia without significant involvement of autonomic and sensory system. Intellect also remain remarkably unaffected. Though the features typically present in first decade of life there are cases which have been reported in later decades of life. The diagnosis is usually established in patients having typical clinical features responding dramatically to oral administration of levodopa. The confirmation of diagnosis depends upon confirming mutation involving the PTS (pyruvoyl tetrahydropterin synthase) gene (Chr11:112104186; G>T).

Though genetic testing is required for confirmation of diagnosis more than 25% of patients with DRD do not show the common mutations. Some of these coding region mutation-negative cases may be due to sporadic mutations, autosomal recessive variety of DRD and TH-deficient DRD. Gene deletions, De novo mutations and incomplete penetrance may be responsible for sporadic cases. In minority of the cases metabolism of dopamine is altered but their neurological functions remain normal and these patients may behave like asymptomatic carriers of mutated genes.

Here by we present a case of DRD in a 7 year old male child with dystonic tremors  and bradykinesia and was proven to have homozygous missense variation in exon 6 of the PTS gene ( Chr11:112104186 ; G>T) that results in the amino acid substitution of Tyrosine for Aspartic acid at codon 116(p.D116Y; ENST00000280362). The patient responded well to L-Dopa.

Keywords: Dopa responsive dystonia , Parkinsonism, Bradykinesia,  PTS gene, L-Dopa.

References

1.      Nomura Y. [The clinical characteristics of involuntary movements in childhood]. No To Hattatsu. 1997 May. 29(3):199-205.

2.      Furukawa Y. [Dopa-responsive dystonia: clinical, genetic, and biochemical studies]. Rinsho Shinkeigaku. 2006 Jan;46(1):19-34.

3.      Hyland K, Kasim S, Egami K, Arnold LA, Jinnah HA. Tetrahydrobiopterin deficiency and dopamine loss in a genetic mouse model of Lesch-Nyhan disease. J Inherit Metab Dis. 2004;27(2):165-78.

4.      Pearl PL. Monoamine neurotransmitter deficiencies. Handb Clin Neurol. 2013;113: 1819-25.

5.      Lee W-W, Jeon BS. Clinical Spectrum of Dopa-Responsive Dystonia and Related Disorders. Current Neurology and Neuroscience Reports. 2014;14(7):461.

6.      Cloud LJ, Jinnah H. Treatment strategies for dystonia. Expert opinion on pharmacotherapy. 2010;11(1):5-15.

7.      Jan MM. Misdiagnoses in children with dopa-responsive dystonia. Pediatr Neurol. 2004 Oct;31(4):298-303.

8.      Kamal N, Bhat D, Carrick E. Dopa-responsive dystonia(Segawa syndrome). Indian Pediatrics 2006; 43: 635-8.

9.      Ye J, Liu XQ, Qiu WJ, Han LS, Zhou JD, Zhang YF, Gu XF. Screening for tetrahydrobiopterin metabolic disorders and related gene analysis among the patients with motor disturbance and mental retardation. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Apr;24(2):210-2.

10.  Wider C, Melquist S, Hauf M, et al. Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1 redefining DYT14 as DYT5. Neurology. 2008;70(16 Pt 2):1377-1383.

11.  Sun Z, Zhang Y, Guo J, et al. Genetic Diagnosis of Two Dopa-Responsive Dystonia Families by Exome Sequencing. Wang K, ed. PLoS ONE. 2014;9(9):e106388.

12.  Thony, B., Blau, N. Mutations in the GTP cyclohydrolase I and 6-pyruvoyl-tetrahydropterin synthase genes. Hum. Mutat. 10: 11-20, 1997.

13.  Dudesek, A., Roschinger, W., Muntau, A. C., Seidel, J., Leupold, D., Thony, B., Blau, N. Molecular analysis and long-term follow-up of patients with different forms of 6-pyruvoyl-tetrahydropterin synthase deficiency. Europ. J. Pediat. 160: 267-276, 2001.

14.  Kong CK, Ko CH, Tong SF, Lam CW. Atypical presentation of dopa-responsive dystonia: generalized hypotonia and proximal weakness. Neurology. 2001 Sep 25;57(6):1121-4.

15.  Bandmann O, Wood NW. Dopa-responsive dystonia -- the story so far. Neuropediatrics. 2002 Feb;33(1):1-5.

Corresponding Author

Dr Shyam Srinivasan

Senior Resident, Dept of Paediatrics,

Grant Government Medical College and Sir J.J Group of Hospitals Mumbai